While Hippo genes have been rarely reported as mutated in human cancers, the recurrent mutations reported in PAK1, RASSF4, HIPK2 and DVL1 in many types of cancer by the Integrative Onco Genomics, a web site that explores driver genes in cancer, suggest they likely play a role in tumorigenesis process. The gene discussed is RASSF4; the disease is cancer.